MS-Perspektive - The Multiple Sclerosis Podcast

The EDSS score helps neurologists to measure the progression of MS as it measures limitations in functional systems. You can find the full article at: https://ms-perspektive.com/75-edss The Expanded Disability Status Scale (EDSS) is a key tool used by neurologists to measure how Multiple Sclerosis (MS) affects your body. Understanding the EDSS can help you gain insight into your condition and assi...

Learn more about the S1P Modulators, known by the brand names Gilenya, Zeposia, Ponvory, Mayzent and their usage against active RRMS & SPMS. You can find the complete text to read on my blog: https://ms-perspektive.com/074-s1p-modulators Today it's all about the group of S1P modulators, which includes fingolimod (Gilenya), ozanimod (Zeposia), ponesimod (Ponvory) and siponimod (Mayzent). The first...

Crys was diagnosed with MS at the age of 11. She talks about her experiences as a first-generation Latina and her mission on social media. You can find all questions and answers on my blog: https://ms-perspektive.com/073-crys   Today I'm talking to Crys about her life with multiple sclerosis as a first generation Latina. Crys was diagnosed at age eleven and experienced her most severe episode at a...

Natalizumab (Tysabri, Tyruko) is approved as disease-modifying therapy (DMT) for active RRMS with a rapidly evolving severe MS. You can read the complete article on my blog: https://ms-perspektive.com/072-natalizumab Today we are talking about natalizumab, which is known under the trade names Tysabri and Tyruko. The immunotherapy is used for active, severe courses of relapsing forms of MS. Nataliz...

Dr. Adriana Casallas V. provides insights into the treatment and care of MS patients in Colombia including improvements and challenges. You can find all questions and answers to read through on my blog: https://ms-perspektive.com/71-adriana-casallas MS has long been known as an orphan disease in Colombia, but the increasing number of newly diagnosed patients is changing this picture. Dr. Adriana C...

Teriflunomide (Aubagio) is approved as disease-modifying therapy for mild to moderate RRMS from 10 years of age. You can find the full article to read on my blog: https://ms-perspektive.com/70-teriflunomide This time it's about teriflunomide, which is known under the trade name Aubagio. The immunotherapy is used for mild to moderate courses of relapsing forms of MS. Teriflunomide also has a broade...

MS patient and advocate Rachel Horne sponsors a prize for women in MS research and campaigns for more diversity in clinical trials. You can read all questions and answers on my blog: https://ms-perspektive.com/69-rachel-horne Rachel Horne was diagnosed with multiple sclerosis at the age of 43, when she felt fit and healthy. She established the Rachel Horne Award to raise the visibility of women in...

Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS. You can find the full article to read on my blog: https://ms-perspektive.com/068-interferons In today's article, I present interferon-beta, which include several active substances and are known as Avonex, Betaferon, Extavia, Plegridy, Rebif, or under other tra...

Discover how speech therapists can address often overlooked MS-related swallowing and communication disorders for timely intervention. You can find the written version to read on my blog: https://ms-perspektive.com/67-speech-therapy Swallowing and speech disorders usually play a subordinate role in the perception of patients. However, problems with swallowing occur in up to 40% and with speech in...

Dr. Sara Samadzadeh contributes to research in the field of NMOSD and MS by creating networks between young researchers worldwide. You can find all questions and answers as well as all links on the blog article: https://ms-perspektive.com/066-sara-samadzadeh Multiple sclerosis and NMOSD have made tremendous advances in treatment due to research conducted over the past decades. Nevertheless, there...

Glatiramer Acetate, brand names Copaxone and Brabio, belongs to the oldest immunotherapies for relapsing remitting multiple sclerosis. You can find the written version of this episode on my blog: https://ms-perspektive.com/065-glatiramer-acetate This time I am presenting glatiramer acetate, which is known as Copaxone, Brabio or other tradenames and is one of the approved disease-modifying drugs fo...

Dr. Meral Seferoglu gives an insight into the treatment of MS in Turkey and how she uses her expertise to support patients. You can read all questions and answers on my blog: https://ms-perspektive.com/64-meral-seferoglu This time I have Dr. Meral Seferoglu as an interview guest on the show and we talk about MS treatment in Turkey. It's always interesting to hear about other countries and how they...

Sexual dysfunction is common in multiple sclerosis. However, there are many ways to overcome them and enjoy intimacy again. You can find the written version of the episode on my blog: https://ms-perspektive.com/63-sexual-dysfunction Sex can be one of the best things in life and sexual dysfunction can therefore cause a lot of frustration. In this article, you will learn about the background and man...

Tecfidera and Vumerity, the fumarates kick-off the informative series about immunotherapy for multiple sclerosis. You can find the full article to read on my blog: https://ms-perspektive.com/62-fumarates Tecfidera and Vumerity, the fumarates, kick off the series on the approved disease-modifying therapies for MS. I am trying to give a good overview, but it does not claim to be complete information...

Bladder disorders in MS are common and remain untreated in half of those affected. Nine simple questions are designed to help treat this symptom earlier. You can find the full article to read on my blog: https://ms-perspektive.com/61-bladder-check Today I would like to introduce the „MS Bladder Check Tool", which was developed by a team of neurologists, urologists and rehabilitation specialists. I...

Sleep disorders in multiple sclerosis can have a negative impact on many symptoms, which is why they should definitely be treated. You can find the transcript of the interview on my blog: https://ms-perspektive.com/60-sleep-challenges This episode is about sleep disorders caused by multiple sclerosis and how they can be treated. Almost three quarters of all people with MS suffer from sleep disorde...

Blake Arnet talks about his motivation for the Dunk MS fundraiser event that takes place each spring in Los Angeles. You can read the full interview on my blog: https://ms-perspektive.com/59-blake-arnet Welcome to today's episode where I talk with Blake Arnet, a former UCLA basketball player, about his fundraising event, Dunk MS. Blake's mother was diagnosed with MS and passed away shortly after....

Choosing the right immunotherapy for each individual patient is a complex process. Prof. Ziemssen explains what needs to be considered. You can read the full transcript of the interview here: https://ms-perspektive.com/58-immunotherapy   Today's interview on immunotherapy for MS marks the start of the series on disease-modifying therapies. It is also episode 250 for the German podcast and I transl...

Depression can bring your everyday life to a complete standstill. Find out when you need help and what services are available. You can read the full article on my blog: https://ms-perspektive.com/57-depression Depression and mood disorders can bring your entire everyday life to a standstill. That's why I'm dedicating this article to negative changes in the psyche. You will find out what triggers t...

Prof. Giancarlo Comi presents the extensive work of the European Charcot Foundation to help improve the lives of people with MS worldwide. You can find the complete transcript of the interview on my blog: https://ms-perspektive.com/56-prof-comi   This time I welcome Prof. Giancarlo Comi, President of the European Charcot Foundation (ECF), for an interview. We talk about the important role of the F...

For women with MS desiring motherhood, controlled MS and informed choices in pregnancy and lactation ensure a fulfilling journey, with modern therapies supporting both mother and child's health. You can find the questions and asnwers to read on my blog:  https://ms-perspektive.com/55-celia-oreja-guevara Prof. Celia Oreja-Guevara advises women with multiple sclerosis and the desire to have children...

Learn more about strategies, tools and medications to manage bladder and bowel symptoms associated with MS to regain your quality of life. You can find the full article to read on my blog: https://ms-perspektive.com/54-bladder-bowel This time it's about bladder and bowel disorders caused by multiple sclerosis. Around two thirds of all people with MS have at least one episode of impaired bladder an...

Discover Prof. Christian Münz's research on the connection between EBV and MS, including theories, mechanisms, and potential treatments. You can find the transcript of the interview on my blog: https://ms-perspektive.com/52-christian-muenz EBV, the Epstein-Barr virus, and its influence and impact on multiple sclerosis has long been a subject of interest to Dr. Christian Münz. As Professor of Viral...

Prof. Kalincik gives insights into the statistical results of treatment regimens and why most PwMS benefit from highly effective therapies. You can find the transcript of the interview to read through on my blog:   https://ms-perspektive.com/52-tomas-kalincik Tomas Kalincik is Professor of Neurology and Applied Statistics at the University of Melbourne and the Royal Melbourne Hospital in Australia...

Pain can be caused directly or indirectly by multiple sclerosis. Find out what you can do to improve your quality of life. You can find the full article to read on my blog: https://ms-perspektive.com/51-pain This time it's about nerve pain caused directly by multiple sclerosis and indirect pain caused by irritated pain receptors. Find out more about the causes and possible approaches to combat the...